Baker Bros. Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-513,410
Closed -$11M 105
2018
Q2
$11M Sell
513,410
-649,234
-56% -$13.4M 0.08% 55
2018
Q1
$25.8M Sell
1,162,644
-343,855
-23% -$9.5M 0.22% 39
2017
Q4
$45.8M Sell
1,506,499
-575,513
-28% -$15.3M 0.4% 26
2017
Q3
$50.4M Hold
2,082,012
0.41% 20
2017
Q2
$51.3M Sell
2,082,012
-521,557
-20% -$11M 0.45% 18
2017
Q1
$56.4M Sell
2,603,569
-400,000
-13% -$8.13M 0.46% 20
2016
Q4
$44.8M Sell
3,003,569
-1,925,925
-39% -$27.8M 0.44% 23
2016
Q3
$63M Buy
4,929,494
+2,349,494
+91% +$25.4M 0.57% 19
2016
Q2
$20.1M Hold
2,580,000
0.21% 32
2016
Q1
$10.3M Buy
+2,580,000
New +$10.9M 0.11% 55

Other funds holding EXEL

Baker Bros. Advisors's EXEL Position: Q3 2018 in Review

Baker Bros. Advisors sold out of Exelixis (EXEL) in Q3 2018, closing a stake of 513,410 shares — an estimated $11M sold.

Baker Bros. Advisors first reported a position in EXEL in Q1 2016 and held it in 10 quarters. The position peaked at $63M in Q3 2016. 316 funds tracked by Wall St. Rank hold EXEL as of Q3 2018.

  • Baker Bros. Advisors reported no remaining Exelixis position as of Q3 2018 after selling out during the quarter.
  • Baker Bros. Advisors sold 513,410 Exelixis shares in Q3 2018, an estimated $11M.
  • Baker Bros. Advisors first reported a position in Exelixis in Q1 2016 and held it in 10 quarters.
  • Baker Bros. Advisors's Exelixis position peaked at $63M in Q3 2016.
  • 316 funds tracked by Wall St. Rank held Exelixis as of Q3 2018.

Based on Baker Bros. Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.